Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial on Efficacy and Tolerability of Two Different Single Doses of Avanafil in Russia

NCT02503306 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT02503306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02503306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial on Efficacy and Tolerability of Two Different Single Doses of Avanafil in Russia
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2015
Completion date
March 31, 2016
Enrollment
189 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sexual function and fertility disorders nec-erectile dysfunction